• Issue

    HemaSphere: Volume 8, Issue 5

    May 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Open Access

Issue Information

  • First Published: 03 May 2024

LETTER

Open Access

First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis

Paolo Ghia,  Carolyn Owen,  John N. Allan,  Jacqueline C. Barrientos,  Paul M. Barr,  Chunxue Shi,  Anita Szoke,  Christopher Abbazio,  Gabriel S. Krigsfeld,  Jan A. Burger, 
  • First Published: 27 May 2024

ARTICLE

Open Access

Remission after CAR T-cell therapy: Do lymphoma patients recover a normal life?

Alya Perthus,  Fanny Colin,  Emilie Charton,  Amélie Anota,  Faustine Lhomme,  Guillaume Manson,  Sophie De Guibert,  Pierre Daufresne,  Adeline Bellec,  Laetitia Le Bars,  Sandra De Barros,  Loïc Ysebaert,  Marianne Merceur,  Mélanie Cogné,  Thierry Lamy De La Chapelle,  Roch Houot,  Aline Moignet, 
  • First Published: 27 May 2024
Remission after CAR T-cell therapy: Do lymphoma patients recover a normal life?

Open Access

An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemia

Zicong Huang,  Ling Zhang,  Xiaoyuan Gong,  Jia Li,  Shiyu Deng,  Zihong Cai,  Bingqing Tang,  Kangyu Huang,  Xin Li,  Weihua Zhao,  Yang Xu,  Li Xuan,  Qifa Liu,  Ying Wang,  Suning Chen,  Hongsheng Zhou, 
  • First Published: 21 May 2024
An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemia

REVIEW ARTICLE

Open Access

Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)

Fabio Efficace,  Rena Buckstein,  Gregory A. Abel,  Johannes M. Giesinger,  Pierre Fenaux,  Jan Philipp Bewersdorf,  Andrew M. Brunner,  Rafael Bejar,  Uma Borate,  Amy E. DeZern,  Peter Greenberg,  Gail J. Roboz,  Michael R. Savona,  Francesco Sparano,  Jacqueline Boultwood,  Rami Komrokji,  David A. Sallman,  Zhuoer Xie,  Guillermo Sanz,  Hetty E. Carraway,  Justin Taylor,  Stephen D. Nimer,  Matteo Giovanni Della Porta,  Valeria Santini,  Maximilian Stahl,  Uwe Platzbecker,  Mikkael A. Sekeres,  Amer M. Zeidan, 
  • First Published: 21 May 2024

ARTICLE

Open Access

Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy

Gloria Iacoboni,  Josu Iraola-Truchuelo,  Maeve O'Reilly,  Víctor Navarro,  Tobias Menne,  Mi Kwon,  Ana África Martín-López,  Sridhar Chaganti,  Javier Delgado,  Claire Roddie,  Ariadna Pérez,  Jane Norman,  Manuel Guerreiro,  Adam Gibb,  Ana Carolina Caballero,  Caroline Besley,  Nuria Martínez-Cibrián,  Alberto Mussetti,  Robin Sanderson,  Hugo Luzardo,  Sunil Iyengar,  Jose Maria Sánchez,  Ceri Jones,  Juan-Manuel Sancho,  Pere Barba,  Anne-Louise Latif,  Lucia López-Corral,  Rafael Hernani,  Juan Luis Reguera,  Anna Sureda,  Alejandro Martin Garcia-Sancho,  Mariana Bastos,  Pau Abrisqueta,  Andrea Kuhnl, 
  • First Published: 21 May 2024

HemaTopics

Open Access

News on sickle cell disease: Heme-driven disordered erythropoiesis

Francesca Vinchi, 
  • First Published: 17 May 2024

GUIDELINES - CONSENSUS-BASED

Open Access

Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium

Cristina A. Tentori,  Lin P. Zhao,  Benedetta Tinterri,  Kathryn E. Strange,  Katharina Zoldan,  Konstantinos Dimopoulos,  Xingmin Feng,  Elena Riva,  Benjamin Lim,  Yannick Simoni,  Vidhya Murthy,  Madeline J. Hayes,  Antonella Poloni,  Eric Padron,  Bruno A. Cardoso,  Michael Cross,  Susann Winter,  Aida Santaolalla,  Bhavisha A. Patel,  Emma M. Groarke,  Daniel H. Wiseman,  Katy Jones,  Lauren Jamieson,  Charles Manogaran,  Naval Daver,  Laura Gallur,  Wendy Ingram,  P. Brent Ferrell,  Katja Sockel,  Nicolas Dulphy,  Nicolas Chapuis,  Anne S. Kubasch,  Astrid M. Olsnes,  Austin Kulasekararaj,  Hugues De Lavellade,  Wolfgang Kern,  Mieke Van Hemelrijck,  Dominique Bonnet,  Theresia M. Westers,  Sylvie Freeman,  Uta Oelschlaegel,  David Valcarcel,  Marco G. Raddi,  Kirsten Grønbæk,  Michaela Fontenay,  Sanam Loghavi,  Valeria Santini,  Antonio M. Almeida,  Jonathan M. Irish,  David A. Sallman,  Neal S. Young,  Arjan A. van de Loosdrecht,  Lionel Adès,  Matteo G. Della Porta,  Catherine Cargo,  Uwe Platzbecker,  Shahram Kordasti,  i4MDS consortium , 
  • First Published: 15 May 2024

ARTICLE

Open Access

Influence of donor–recipient sex on engraftment of normal and leukemia stem cells in xenotransplantation

Syed A. Mian,  Linda Ariza-McNaughton,  Fernando Anjos-Afonso,  Remisha Gurung,  Sophie Jackson,  Aytug Kizilors,  John Gribben,  Dominique Bonnet, 
  • First Published: 21 May 2024

Influence of donor–recipient sex on engraftment of normal and leukemia stem cells in xenotransplantation

HemaTopics

Open Access

When to stop: Transfusions, difficult conversations and creativity

Sophie Evans,  Stephen P. Hibbs, 
  • First Published: 28 May 2024

REVIEW ARTICLE

Open Access

Interplay between α-thalassemia and β-hemoglobinopathies: Translating genotype–phenotype relationships into therapies

Jim Vadolas,  Tiwaporn Nualkaew,  Hsiao P. J. Voon,  Shahla Vilcassim,  George Grigoriadis, 
  • First Published: 15 May 2024

LETTER

Open Access

T-cell lymphoblastic lymphoma in constitutional mismatch repair deficiency (CMMRD): Exploring treatment opportunities

Emma Kroeze,  Dilys D. Weijers,  Michelle M. Kleisman,  Uri Ilan,  Reno S. Bladergroen,  Rico Hagelaar,  Jules P. P. Meijerink,  Marjolijn C. J. Jongmans,  Jan L. C. Loeffen,  Roland P. Kuiper, 
  • First Published: 12 May 2024

ARTICLE

Open Access

Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML

Mélanie Lambert,  Samy Jambon,  Mohamed A. Bouhlel,  Sabine Depauw,  Julie Vrevin,  Samuel Blanck,  Guillemette Marot,  Martin Figeac,  Claude Preudhomme,  Bruno Quesnel,  David W. Boykin,  Marie-Hélène David-Cordonnier, 
  • First Published: 06 May 2024

Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML

 

Open Access

The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma

Anna de Daniel,  Luis Gerardo Rodríguez-Lobato,  Natalia Tovar,  M. Teresa Cibeira,  David F. Moreno,  Aina Oliver-Caldés,  Ignacio Isola,  Ester Lozano,  Joan Bladé,  Laura Rosiñol,  Carlos Fernández de Larrea, 
  • First Published: 06 May 2024
The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma